NCT02262052View on ClinicalTrials.gov

Advanced Diagnostic Management of Suspected Recurrent Ipsilateral DVT With MRDTI

NACompletedINTERVENTIONAL
Enrollment

305

Participants

Timeline

Start Date

March 26, 2015

Primary Completion Date

March 31, 2019

Study Completion Date

March 31, 2019

Conditions
Deep Vein Thrombosis
Interventions
OTHER

MRDTI

MRDTI is primary diagnostic test for management of suspected ipsilateral DVT

Trial Locations (12)

Unknown

Ottawa Hospital, Ottawa

RAMBAM Healthcare center, Haifa

AMC, Amsterdam

Rijnstate, Arnhem

Deventer Ziekenhuis, Deventer

HAGA, The Hague

MCH Westeinde, The Hague

UMCU, Utrecht

Ostfold Hospital Trust, Grålum

Danderyds sjukhus, Stockholm

2333 ZA

LUMC, Leiden

3582 KE

Diakonessenhuis Utrecht, Utrecht

All Listed Sponsors
collaborator

Trombosestichting Nederland

UNKNOWN

lead

Leiden University Medical Center

OTHER

NCT02262052 - Advanced Diagnostic Management of Suspected Recurrent Ipsilateral DVT With MRDTI | Biotech Hunter | Biotech Hunter